Investors

NevoMD is launching in Q1 2026 and is preparing to scale our product, operations, and go-to-market execution.

We are seeking $1M+ in seed funding to accelerate development, compliance readiness, and customer acquisition. If you are interested in learning more, please contact us through the Contact page.